The moment an executive team sits down to plan an aggressive market expansion, a subtle shift almost always happens in the room.
Nobody talks about it during initial debt negotiations, but it shows up in board meetings whenever growth decisions come up:
"Should we double our ad spend for the Q3 product launch?" > "Better hold back. If sales take an extra month to convert, we might dip below our quarterly DSCR requirement."
"Can we hire those three senior engineers this quarter?" > "Let's push it to next year. We need to keep our leverage ratio clean for the bank's end of year audit."
The business isn't in financial trouble. It’s growing and making money. But because the debt package carries tight quarterly covenants to justify its low interest rate, management naturally starts playing defense.
This defensive mindset rarely shows up on a short term P&L. On paper, you are saving money on interest and keeping your bank happy.
The real cost hits later, when you step up to the table to sell the business or raise a major growth round.
When a buyer evaluates a business, they don't look at how much interest you saved during your operating cycle. They look at two primary numbers: your EBITDA and your growth velocity.
Those two numbers determine your enterprise value (Enterprise Value = EBITDA × Multiple).
When rigid debt terms force a management team to play defense, it creates a compounding double whammy on your valuation at exit:
Let's look at how this plays out on a real world balance sheet over a 3 year operating window.
Assume a company starting at £1.5M EBITDA raises £5M in growth capital and is choosing between two options:
Option A (Traditional Bank Loan): 6.5% headline interest rate with strict quarterly maintenance covenants and monthly principal amortization.
Option B (Structured Capital): 9.0% nominal interest rate with an 18 month interest only window and covenant light terms.
Because Option A amortizes down over time, saving 2.5% in nominal interest saves the company roughly £112,500 in Year 1, totaling approximately £280,000 in net interest savings over the 3 year period.
Under Option A (Playing Defense): Tight quarterly covenants forced management to hold back on hiring and ad spend. EBITDA growth slowed to 10% annually, reaching £2.0M EBITDA. Because growth slowed, buyers price it as a steady operator at a 7x multiple.
Enterprise Value: £2.0M EBITDA × 7 = £14.0M
Under Option B (Executing Growth): Cov light terms and an interest only window allowed management to aggressively deploy capital. EBITDA grew at 25% annually, reaching £2.9M EBITDA. Buyers view it as a category leader and apply a 10x multiple.
Enterprise Value: £2.9M EBITDA × 10 = £29.0M
By saving £280,000 in interest over three years, playing it safe under rigid debt terms cost the shareholders £15.0M in enterprise value at exit (£29.0M vs. £14.0M).
The fundamental flaw in evaluating debt purely on headline interest is assuming that all £5M facilities impact your operations equally. They don't.
If your operational Return on Invested Capital (ROIC) is 20% or higher, every pound retained inside the business and deployed into growth builds compounding equity value.
Paying a slightly higher nominal yield for a facility that offers flexible covenant headroom isn't "expensive capital." It’s an investment in growth velocity. It gives your management team the confidence to execute aggressive market pushes without constantly glancing over their shoulder at a bank compliance calendar.
Before accepting a low rate proposal based on line item interest savings, run this quick check with your board:
When enterprise value is the ultimate goal, preserving growth velocity is far more valuable than saving a few hundred basis points on headline interest.
Get the exact side-by-side £5M facility comparison, including Year 1 cash-drain breakdowns, side-by-side covenant matrices, and our 20% ROIC working capital sensitivity model.
Book an exploratory discussion with Fuse Capital to review your capital requirements and build a debt structure tailored to your business strategy.